References
- ACOG. 1999. ACOG practice bulletin. Prevention of Rh D alloimmunization. No. 4, May 1999 (replaces Educational Bulletin No. 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. International Journal of Gynaecology and Obstetrics 66:63–70.
- Biankin SA, Arbuckle SM, Graf NS. 2003. Autopsy findings in a series of five cases of fetomaternal haemorrhages. Pathology 35:319–324.
- Bowman JM, Pollock JM, Penston LE. 1986. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sanguinis 51:117–121.
- Creasy R, Resnik R. 1994. Maternal fetal medicine, principles and practice. Philadelphia: WB Saunders. p. 1157.
- Freese UE, Titel JH. 1963. Demonstration of fetal erythrocytes in maternal circulation. Obstetrics and Gynecology 22:527–532.
- Gardner RJ, Sutherland GR. 2004. Chromosomal abnormalities and genetic counselling. 3rd ed. Oxford: Oxford University Press. p 90–91.
- Laube DW, Schauberger CW. 1982. Fetomaternal bleeding as a cause for ‘unexplained’ fetal death. Obstetrics and Gynecology 60:649–651.
- NICE. 2008. Routine antenatal anti-D prophylaxis for women who are rhesus D negative. London: NICE.
- Samadi R, Greenspoon JS, Gviazda I, Settlage RH, Goodwin TM. 1999. Massive fetomaternal hemorrhage and fetal death: are they predictable? Journal of Perinatology 19:227–229.
- Schroder J. 1975. Transplacental passage of blood cells. Journal of Medical Genetics 12:230–242.